Skip to main content
Top
Published in: Medical Oncology 8/2019

01-08-2019 | Breast Cancer | Original Paper

A study of mechanistic mapping of novel SNPs to male breast cancer

Authors: Raman Preet Kaur, Vicky Kumar, Gowhar Shafi, Rajesh Vashistha, Mahesh Kulharia, Anjana Munshi

Published in: Medical Oncology | Issue 8/2019

Login to get access

Abstract

Alterations in BRCA2, PALB2, CHEK2, and p53 genes have been identified for their association with male breast cancer in various studies. The incidence of male breast cancer in India is consistent with its global rate. The present study was carried out with an aim to evaluate the genetic alterations in male breast cancer patients from Malwa region of Punjab, India. Four male breast cancer patients belonging to different families were recruited from Guru Gobind Singh Medical College and Hospital, Faridkot, India. A total of 51 genes reported with implications in the pathogenesis of breast cancer were screened using next generation sequencing. Germline variations were found in BRCA1, BRCA2, PMS2, p53, and PALB2 genes, previously reported to be associated with MBC as well as FBC. In addition to these, 13 novel missense alterations were detected in eight genes including STK11, FZR1, PALB2, BRCA2, NF2, BAP1, BARD1, and CHEK2. Impact of these missense alterations on structure and function of protein was also analyzed through molecular dynamics simulation. Structural analysis of these single nucleotide polymorphisms (SNPs) revealed significant impact on the encoded protein functioning.
Appendix
Available only for authorised users
Literature
1.
go back to reference Staruch RM, Rouhani MJ, Ellabban M. The surgical management of male breast cancer: time for an easy access national reporting database? Ann Med Surg. 2016;1(9):41–9.CrossRef Staruch RM, Rouhani MJ, Ellabban M. The surgical management of male breast cancer: time for an easy access national reporting database? Ann Med Surg. 2016;1(9):41–9.CrossRef
3.
go back to reference Yoney A, Kucuk A, Unsal M. Male breast cancer: a retrospective analysis. Cancer/Radiothérapie. 2009;13(2):103–7.CrossRef Yoney A, Kucuk A, Unsal M. Male breast cancer: a retrospective analysis. Cancer/Radiothérapie. 2009;13(2):103–7.CrossRef
4.
go back to reference Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS. Male breast cancer: is the incidence increasing? Ann Surg Oncol. 2004;11(8):751–5.CrossRef Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS. Male breast cancer: is the incidence increasing? Ann Surg Oncol. 2004;11(8):751–5.CrossRef
5.
go back to reference Sundriyal D, Kotwal S, Dawar R, Parthasarathy KM. Male breast cancer in India: series from a cancer research centre. Indian J Surg Oncol. 2015;6(4):384–6.CrossRef Sundriyal D, Kotwal S, Dawar R, Parthasarathy KM. Male breast cancer in India: series from a cancer research centre. Indian J Surg Oncol. 2015;6(4):384–6.CrossRef
6.
go back to reference Ojara EA. Carcinoma of the male breast in Mulago Hospital, Kampala. East Afr Med J. 1978;55(10):489–91.PubMed Ojara EA. Carcinoma of the male breast in Mulago Hospital, Kampala. East Afr Med J. 1978;55(10):489–91.PubMed
7.
go back to reference Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M, Gulino M, Frati P, Ottini L. Male breast cancer: genetics, epigenetics, and ethical aspects. Ann Oncol. 2013;24(suppl_8):viii75–82.PubMed Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M, Gulino M, Frati P, Ottini L. Male breast cancer: genetics, epigenetics, and ethical aspects. Ann Oncol. 2013;24(suppl_8):viii75–82.PubMed
8.
go back to reference Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS, Goldgar DE, Shimelis H, Couch FJ, Chao EC, LaDuca H. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat. 2017;161(3):575–86.CrossRef Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS, Goldgar DE, Shimelis H, Couch FJ, Chao EC, LaDuca H. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat. 2017;161(3):575–86.CrossRef
9.
go back to reference Fostira F, Saloustros E, Apostolou P, Vagena A, Kalfakakou D, Mauri D, Tryfonopoulos D, Georgoulias V, Yannoukakos D, Fountzilas G, Konstantopoulou I. Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer. Breast Cancer Res Treat. 2018;169(1):105–13.CrossRef Fostira F, Saloustros E, Apostolou P, Vagena A, Kalfakakou D, Mauri D, Tryfonopoulos D, Georgoulias V, Yannoukakos D, Fountzilas G, Konstantopoulou I. Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer. Breast Cancer Res Treat. 2018;169(1):105–13.CrossRef
10.
go back to reference Huang H, Shen H, Wang Y, Wang X, Chen Q, Yan H, Liu Z, Shi X. LOH12CR10 is a novel tumor suppressor inhibiting tumor growth through deregulation of G1/S checkpoint in human colorectal carcinoma. Curr Mol Med. 2018;18(1):25–35.CrossRef Huang H, Shen H, Wang Y, Wang X, Chen Q, Yan H, Liu Z, Shi X. LOH12CR10 is a novel tumor suppressor inhibiting tumor growth through deregulation of G1/S checkpoint in human colorectal carcinoma. Curr Mol Med. 2018;18(1):25–35.CrossRef
11.
go back to reference Tang X, Chen Z, Deng M, Wang L, Nie Q, Xiang JW, Xiao Y, Yang L, Liu Y, Li DW. The sumoylation modulated tumor suppressor p53 regulates cell cycle checking genes to mediate lens differentiation. Curr Mol Med. 2018;18(8):556–65.CrossRef Tang X, Chen Z, Deng M, Wang L, Nie Q, Xiang JW, Xiao Y, Yang L, Liu Y, Li DW. The sumoylation modulated tumor suppressor p53 regulates cell cycle checking genes to mediate lens differentiation. Curr Mol Med. 2018;18(8):556–65.CrossRef
12.
go back to reference Bell R, Barraclough R, Vasieva O. Gene expression meta-analysis of potential metastatic breast cancer markers. Curr Mol Med. 2017;17(3):200–10.CrossRef Bell R, Barraclough R, Vasieva O. Gene expression meta-analysis of potential metastatic breast cancer markers. Curr Mol Med. 2017;17(3):200–10.CrossRef
13.
go back to reference Cabanillas R, Diñeiro M, Castillo D, Pruneda PC, Penas C, Cifuentes GA, de Vicente A, Durán NS, Álvarez R, Ordóñez GR, Cadiñanos J. A novel molecular diagnostics platform for somatic and germline precision oncology. Mol Genet Genom Med. 2017;5(4):336–59.CrossRef Cabanillas R, Diñeiro M, Castillo D, Pruneda PC, Penas C, Cifuentes GA, de Vicente A, Durán NS, Álvarez R, Ordóñez GR, Cadiñanos J. A novel molecular diagnostics platform for somatic and germline precision oncology. Mol Genet Genom Med. 2017;5(4):336–59.CrossRef
14.
go back to reference Gréen A, Gréen H, Rehnberg M, Svensson A, Gunnarsson C, Jonasson J. Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes. J Mol Diagn. 2015;17(1):31–42.CrossRef Gréen A, Gréen H, Rehnberg M, Svensson A, Gunnarsson C, Jonasson J. Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes. J Mol Diagn. 2015;17(1):31–42.CrossRef
15.
go back to reference Krieger E, Vriend G. New ways to boost molecular dynamics simulations. J Comput Chem. 2015;36(13):996–1007.CrossRef Krieger E, Vriend G. New ways to boost molecular dynamics simulations. J Comput Chem. 2015;36(13):996–1007.CrossRef
16.
go back to reference Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics. 2010;27(3):343–50.CrossRef Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics. 2010;27(3):343–50.CrossRef
17.
go back to reference Lovell SC, Davis IW, Arendall WB III, De Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC. Structure validation by Cα geometry: ϕ, ψ and Cβ deviation. Proteins Struct Funct Bioinform. 2003;50(3):437–50.CrossRef Lovell SC, Davis IW, Arendall WB III, De Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC. Structure validation by Cα geometry: ϕ, ψ and Cβ deviation. Proteins Struct Funct Bioinform. 2003;50(3):437–50.CrossRef
18.
go back to reference Berendsen HJ, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun. 1995;91(1–3):43–56.CrossRef Berendsen HJ, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun. 1995;91(1–3):43–56.CrossRef
19.
go back to reference Chikaraddi SB, Krishnappa R, Deshmane V. Male breast cancer in Indian patients: is it the same? Indian J Cancer. 2012;49(3):272.CrossRef Chikaraddi SB, Krishnappa R, Deshmane V. Male breast cancer in Indian patients: is it the same? Indian J Cancer. 2012;49(3):272.CrossRef
20.
go back to reference Rai B, Ghoshal S, Sharma SC. Breast cancer in males: a PGIMER experience. J Cancer Res Ther. 2005;1(1):31.CrossRef Rai B, Ghoshal S, Sharma SC. Breast cancer in males: a PGIMER experience. J Cancer Res Ther. 2005;1(1):31.CrossRef
21.
go back to reference Shah P, Robbani I, Shah O. Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med. 2009;29(4):288.CrossRef Shah P, Robbani I, Shah O. Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med. 2009;29(4):288.CrossRef
22.
go back to reference Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28(2):232.CrossRef Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28(2):232.CrossRef
23.
go back to reference Tan Y, Raychaudhuri P, Costa RH. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol. 2007;27(3):1007–16.CrossRef Tan Y, Raychaudhuri P, Costa RH. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol. 2007;27(3):1007–16.CrossRef
26.
go back to reference Kim Y, Jho EH. Regulation of the Hippo signaling pathway by ubiquitin modification. BMB Rep. 2018;51(3):143.CrossRef Kim Y, Jho EH. Regulation of the Hippo signaling pathway by ubiquitin modification. BMB Rep. 2018;51(3):143.CrossRef
27.
go back to reference Hart SN, Hoskin T, Shimelis H, Moore RM, Feng B, Thomas A, Lindor NM, Polley EC, Goldgar DE, Iversen E, Monteiro AN. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models. Genet Med. 2018;8:1. Hart SN, Hoskin T, Shimelis H, Moore RM, Feng B, Thomas A, Lindor NM, Polley EC, Goldgar DE, Iversen E, Monteiro AN. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models. Genet Med. 2018;8:1.
28.
go back to reference Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121.CrossRef Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121.CrossRef
30.
go back to reference Park JY, Singh TR, Nassar N, Zhang F, Freund M, Hanenberg H, Meetei AR, Andreassen PR. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene. 2014;33(40):4803.CrossRef Park JY, Singh TR, Nassar N, Zhang F, Freund M, Hanenberg H, Meetei AR, Andreassen PR. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene. 2014;33(40):4803.CrossRef
Metadata
Title
A study of mechanistic mapping of novel SNPs to male breast cancer
Authors
Raman Preet Kaur
Vicky Kumar
Gowhar Shafi
Rajesh Vashistha
Mahesh Kulharia
Anjana Munshi
Publication date
01-08-2019
Publisher
Springer US
Published in
Medical Oncology / Issue 8/2019
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-019-1290-0

Other articles of this Issue 8/2019

Medical Oncology 8/2019 Go to the issue